ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,317Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 19

$548K Total Retail Price of All Prescriptions

Rank: 6 out of 19

1,109 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Colorado
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

22% of this provider’s 1,109 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

9% of this provider’s 1,109 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 487 482* 142 1 1
LISINOPRIL 400 385 108 2 4
HYDROCODONE-ACETAMINOPHEN 342 279 95 S3 3 6
FUROSEMIDE 331 326* 95 4 2
SIMVASTATIN 270 265* 83 5 9
AMLODIPINE BESYLATE 227 213 65 6 8
METOPROLOL TARTRATE 220 215* 75 7 7
OMEPRAZOLE 191 186* 74 8 10
GABAPENTIN 186 166 52 9 5
LORAZEPAM 186 157 70 B 9 22
OXYCODONE HCL 175 136 78 S2 11 30
METFORMIN HCL 162 157* 42 12 21
OXYCODONE-ACETAMINOPHEN 158 136 52 S2 13 49
ESCITALOPRAM OXALATE 146 141* 39 14 18
ATORVASTATIN CALCIUM 146 141* 45 14 15
CITALOPRAM HBR 141 136* 36 16 13
WARFARIN SODIUM 137 132* 37 17 3
METOPROLOL SUCCINATE 135 130* 34 18 23
ALPRAZOLAM 133 110 20 B 19 54
HYDROCHLOROTHIAZIDE 129 124* 38 20 28
LOSARTAN POTASSIUM 126 126 28 21 31
TAMSULOSIN HCL 111 106* 38 22 27
DONEPEZIL HCL 104 99* 29 23 12
LOVASTATIN 104 99* 34 23 94
ZOLPIDEM TARTRATE 101 78 32 25 69
LYRICA 101 88 14 25 81
MORPHINE SULFATE ER 99 68 40 S2 27 53
ATENOLOL 98 93* 31 28 40
FENTANYL 97 85 35 S2 29 35
ALLOPURINOL 95 90* 33 30 48
CLOPIDOGREL 94 89* 29 31 37
POTASSIUM CHLORIDE 93 88* 25 32 14
GALANTAMINE HBR 92 92 22 33 138
TRAMADOL HCL 86 81* 44 34 16
CLONAZEPAM 80 61 12 B 35 62
NAMENDA 79 74* 23 36 11
RANITIDINE HCL 79 79 25 36 44
TRAZODONE HCL 68 63* 24 38 26
ALENDRONATE SODIUM 61 56* 15 39 72
ISOSORBIDE MONONITRATE ER 59 59 17 40 96
PREDNISONE 59 54* 25 40 33
LIDOCAINE 58 53* 25 42 99
CELEBREX 57 52* 13 43 110
VOLTAREN 57 57 24 43 71
PRAVASTATIN SODIUM 57 57 17 43 79
OXYCONTIN 55 34 29 S2 46 63
PROAIR HFA 54 49* 24 47 168
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 48* 17 48 169
NEXIUM 51 46* 16 49 117
SERTRALINE HCL 50 45* 19 50 19
GLIPIZIDE 50 45* 12 50 75
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.